Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-12

FDA Approved: METHOCARBAMOL — Original Application (FH2 PHARMA LLC)

View source ↗

Summary

FDA approved FH2 PHARMA LLC's original application for methocarbamol (generic) under the ANDA pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOCARBAMOL (Methocarbamol)

Snippet

ORIG AP for METHOCARBAMOL (METHOCARBAMOL)